Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Библиографические подробности
Главный автор:	Zaman, Rubaiyat
Другие авторы:	Sharmin, Sabrina
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Online-ссылка:	http://hdl.handle.net/10361/23157

Схожие документы

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
по: Mostofa, Golam
Опубликовано: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
по: Dey, Manashi
Опубликовано: (2024)

Role of epigenetics in the development of metabolic disorders: a review
по: Mita, Tanzia Mohsin
Опубликовано: (2024)

Role of circular RNA in neurological disease
по: Salsabil, Labiba
Опубликовано: (2024)

Gene editing for neurodegenerative diseases-A review
по: Sharna, Anika Islam
Опубликовано: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
по: Annee, Israt Jahan
Опубликовано: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
по: Afsana, Nourin
Опубликовано: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
по: Chowdhury, Sariya Uzrat
Опубликовано: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
по: Ferdous, Labiba
Опубликовано: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
по: Tabassum, Nadira
Опубликовано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
по: Shehab, Habibul Mohsin
Опубликовано: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
по: Afreen, Nuraia
Опубликовано: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
по: Karmaker, Swastika
Опубликовано: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
по: Key, Nasrin Sultana
Опубликовано: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
по: Tamanna, Mst. Taskia
Опубликовано: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
по: Tasneem, Sadia
Опубликовано: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
по: Saha, Bithi Rani
Опубликовано: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
по: Chowdhury, Amal
Опубликовано: (2024)

A review on cardiovascular development and epigenetics
по: Srity, Nafisa Alam
Опубликовано: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020)

Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022)

Alzheimer's disease and marriage : an intimate account /
по: Wright, Lore K.
Опубликовано: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
по: Abedin, Khondokar Mezbahul
Опубликовано: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
по: Tasin, Md Abtahi
Опубликовано: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
по: Aziz, Farhin
Опубликовано: (2019)

Infection and communicable diseases /
по: Brettle, Raymond Patrick
Опубликовано: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
по: Afra, Sumaiya
Опубликовано: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
по: Mahee, Sadique Abdal
Опубликовано: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
по: Rumman, Mosarrat, и др.
Опубликовано: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
по: Rawshan, A. E. Maisha
Опубликовано: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
по: Nayeem, Abdullah Al
Опубликовано: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Опубликовано: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
по: Islam, Md. Rakibul
Опубликовано: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
по: Halim, Rabea
Опубликовано: (2022)